** Shares of India's Sun Pharmaceutical Industries SUN.NS
up nearly 2% to a record high of 1,634 rupees, its fourth
all-time high this month
** If gains hold, stock set to rise for fourth straight
quarter and fifth consecutive month
** Of the pharma stocks on the benchmark Nifty 50 index
.NSEI , SUN, Cipla CIPL.NS have avg analysts' rating of "buy"
- LSEG data
** Dr Reddy's Laboratories REDY.NS has "hold", Divi's
Laboratories DIVI.NS "sell"
** Chart below shows most pharma stocks on Nifty 50 index,
incl SUN, which have outperformed the benchmark in FY2024:
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Pharma vs Nifty 50 https://tmsnrt.rs/3JgniOp
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
(Reporting by Rama Venkat in Bengaluru)
((ramavenkat.raman@thomsonreuters.com; https://twitter.com/ramavenkat0607;))